Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07168122

Establishment and Clinical Application of Reference Intervals of Salivary Cortisol

Study for Reference Intervals and Optimal Cut-offs for Salivary Cortisol

Status
Recruiting
Phase
Study type
Observational
Enrollment
220 (estimated)
Sponsor
Shanghai 6th People's Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

The goal of this observational study is to establish the normal reference intervals of salivary cortisol and optimal cut-offs for Cushing's sydrome and adrenal insufficiency.

Detailed description

Saliva testing is a non-invasive alternative to blood tests for measuring cortisol, a key hormone for assessing endocrine status and diagnosing conditions like Cushing's syndrome. It accurately reflects physiologically active free cortisol. However, its clinical use is hampered by extremely low cortisol concentrations and the lack of reliable detection methods. We have developed two advanced technologies: an immunomagnetic-bead-based LC-MS assay with simplified preparation, and a fluorescence immunoassay system for point-of-care testing. To promote their clinical adoption, this study will establish normal reference intervals of salivary cortisol for both methods in a healthy population and optimal cut-offs in cases of Cushing's sydrome and adrenal insufficiency.

Conditions

Timeline

Start date
2025-09-01
Primary completion
2027-06-30
Completion
2027-12-31
First posted
2025-09-11
Last updated
2025-09-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07168122. Inclusion in this directory is not an endorsement.